3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
CNS
1
Conditions
Head and Neck Neoplasms
3
Motor Activity
2
Fatigue
2
Uterine Cervical Neoplasms
1
Trismus
1
Sarcoma
1
Pancreatic Neoplasms
1
Esophageal Neoplasms
1
Carcinoma, Bronchogenic
1
Brain Neoplasms
1
Accessory Nerve Injuries
1
Interventions
pembrolizumab
11
Nivolumab
6
Cetuximab
5
Gemcitabine
4
Filgrastim
4
Cisplatin
4
Carboplatin
4
tislelizumab
3
Radiosurgery
3
Ipilimumab
3
Injections
3
Fluorouracil
3
Docetaxel
3
Cyclophosphamide
3
Bortezomib
3
toripalimab
2
spartalizumab
2
poly ICLC
2
pazopanib
2
entrectinib
2
durvalumab
2
cemiplimab
2
belinostat
2
atezolizumab
2
Temozolomide
2
Surveys and Questionnaires
2
Riluzole
2
Peripheral Blood Stem Cell Transplantation
2
Oncolytic Virotherapy
2
Etoposide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma
×
Exercise Therapy
×
Head & Neck
×
Clear all
NCT04517019
2020-08-18
OnkoFit II
University Hospital Tuebingen
Phase NA
Unknown
201 enrolled